A lot of it has been just to open up the discourse. Quite clearly the companies have asked for transparency in the Pharmac decision-making process. They would be comfortable, I think, Heather, if they were able to sit there when the decisions were being made, to hear that their medicine hasn't been funded for the following reasons. There are delays even in getting those decisions out to them, and time is a pressure for everyone in business.
Those are the sorts of solutions that we've asked for, improvement in the actual processes. I think even politicians in New Zealand from all different parties have also seen that a simple solution is actually to fund it at the correct level. Have we gone too conservative in the way that we actually fund the medicines? I think today we've talked about the evidence that indicates we may have.
Just getting the funding equation correct is a problem for every government, and we want to be part of that solution.